Evaluation of Nu.Q™ H3.1 in K2-EDTA Plasma Obtained from Normal Subjects and from Subjects Diagnosed with Benign, Cancerous, or Other Diseases of Interest
SUB-STUDY TITLE: “Evaluation of Nu.Q™H3.1 Test in K2-EDTA Plasma Obtained from Normal Subjects and Subjects with Relevant Benign Conditions” (“NORBEN”)
PROTOCOL NUMBER: VOL-003 (NORBEN)
WCG IRB Protocol #20224964
SPONSOR: Volition America, Inc.
INVESTIGATOR: Suzanne Rose, MS, PhD, CCRC, FACRP
The Stamford Hospital
Thank you for your interest in the Volition NORBEN study. This form will ask if you have been diagnosed with one of the specific conditions as well as ask for your contact information so the study team can call to schedule your study visit. If you are interested in participating, please continue to the next page.
